Transferrin (Tf) is the major iron binding protein in vertebrate serum. It shares homologous amino acid sequences with four other proteins: lactotransferrin, ovotransferrin, melanoma antigen p97, and HuBlym-l. Antigen p97 and the Tf receptor genes have been mapped on human chromosome 3. The goal of the study described here was to initiate the characterization of the Tf gene by identifying and characterizing its cDNA and mapping its chromosomal location. Recombinant plasmids containing human cDNA encoding Tf have been isolated by screening an adult human liver library with a mixed oligonucleotide probe. Within the 2.3 kilobase pairs of TfcDNA analyzed, there is a probable leader sequence encoded by 57 nucleotides followed by 2037 nucleotides that encode the homologous amino and carboxyl domains. During evolution, three areas of the homologous amino and carboxyl domains have been strongly conserved, possibly reflecting functional constraints associated with iron binding. Chromosomal mapping by in situ hybridization and somatic cell hybrid analysis indicate that the Tfgene is located at q21-25 on human chromosome 3, consistent with linkage of the Tf, Tf receptor, and melanoma p97 loci.Transferrin (Tf) carries ferric iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. The family of Tf-like proteins represents the product of an intragenic duplication followed by a series of independent gene duplications (1-4). Serum Tf (1), hen ovotransferrin (2, 3), lactotransferrin (4), melanoma antigen p97 (5), and a transforming protein from chicken lymphoma ChBlym-1 (6) share strong amino acid sequence homologies. A transforming protein from Burkitt lymphomas recently described (7) may also belong to the Tf family. There is also significant internal homology in the amino-terminal (NH2) and carboxyl-terminal (COOH) domains of Tf, lactotransferrin, and ovotransferrin (1-4). For example, the NH2 and COOH domains of human Tf reveal 40% identity when the NH2 domain (residues 1-336) and the COOH domain (residues 337-678) are compared (1). In the study described Screening of cDNA Clones. The cDNA library, kindly provided by Stuart H. Orkin (Harvard Medical School, Boston) was constructed from human liver RNA as described (10). The cDNA library was incubated overnight on L agar plates containing 10 jig of tetracycline per ml and was transferred to nitrocellulose filters. The plasmids were amplified with 250 ,tg of chloramphenicol per ml and the filters were prepared for hybridization as described by Grunstein and Hogness (11). The filters were hybridized at 37°C with 32P-labeled oligonucleotide mixed probes as described by Wallace, et al. (12). The hybridization mixture contained 0.9 M NaCl, 0.09 M Tris HCl (pH 7.5), 0.006 M EDTA, 0.5% NaDodSO4, Denhardt's (13) solution (5 x strength), 100 ,ug of denatured Escherichia coli DNA per ml, and 6.4 ng of 5' end-labeled oligonucleotide mixed probes per ml having a specific activity of -7 x 108 cpm/,ug.Preparation...
Ceruloplasmin (CP) is a copper-binding protein in vertebrate plasma. It is the product of an intragenic triplication and is composed of three homologous domains. Oligonucleotide probes constructed according to published amino acid sequences were used to identify cDNA clones encoding human CP. Two clones, CP-1 and CP-2, differed from each other by the presence or absence, respectively, of a deduced sequence of four amino acids. The two clones provided 81% of the sequence encoding CP. Comparison of the nucleotides of the three domains of the CP coding sequence revealed internal domain homology with identity of sequences ranging from 50.1% to 56%. The nucleotide sequence of CP-2 cDNA was compared to that of a homologous human protein, clotting factor VIII, and was found to be 48% identical overall. The CP gene was mapped to human chromosome 3 by somatic-cellhybrid analysis and to 3q25 by in situ hybridization; however, sites of hybridization to DNA on other chromosomal sites suggested additional CP-like DNA sequences in the human genome. A DNA polymorphism was detected with CP cDNA after endonuclease digestion of human DNA by Pst I. CP mRNA was detected in human liver, macrophages, and lymphocytes by in situ histohybridization.
In summary, the work reviewed in the present paper indicates that 1. Iron and the iron-binding proteins can act as regulators of immune function, and not only as a result of a nutritional dependence of lymphoid cells on transferrin and transferrin-iron. Subsets of cells of the immune system respond differently to increases in iron concentration in vitro and in vivo. 2. Macrophages and lymphocytes differ in the H and L subunit content of the ferritins synthesized in response to increases in iron concentration in vitro. 3. NK activity by adherent and nonadherent cells differ in their susceptibility to the enhancing effect of lactoferrin in vitro. 4. Responses to mitogen stimulation by PHA and Con A are diminished, while the PWM response remains unaffected by exposure to acidic ferritins or by increasing concentrations of iron in vitro and in vivo. 5. Pretreatment of effector but not target cells with iron results in diminished responses in the MLR, an effect that appears to be related to the HLA-A locus. 6. In situ hybridization studies indicate that transferrin is synthesized by a specific subset of the T lymphocytes. 7. Transient increases in serum iron concentration above the full saturation of transferrin, reproducing the clinical situation frequently seen in hereditary hemochromatosis, are followed by a series of cellular changes in the synovium that can be correlated to changes in the course of an experimental model of arthritis in the rat.
No abstract
Human follicular fluid from healthy mature Graafian follicles and from pathologic ovarian cyst fluid was found to be inhibitory to progesterone-induced meiotic maturation of oocytes from the South African clawed toad, Xenopus laevis. Human follicular fluid but not human serum, collected from the same individuals, demonstrated a linear dose-response inhibition on the maturation of oocytes in the Xenopus assay system. These findings indicate that the human follicular and cyst fluids contain oocyte maturation inhibitor (OMI). This human OMI was inactivated when subjected to a boiling water bath for 2 min. The OMI action was shown to be reversible in its inhibitory action. The fact that OMI can act directly on the oocyte was demonstrated by its inhibitory action on maturation in defolliculated oocytes. The findings demonstrate that the inhibitory action of human OMI is not species-specific. Xenopus oocytes provide a simple, readily available, year-round bioassay material for testing follicular oocyte maturation inhibitor.
Amiloride and seven of its analogues, as well as seven substances of other structural types, all of which control electrolyte transport, were tested for their effectiveness for inhibiting the progesterone‐stimulated meiotic maturation cycle of oocytes from the amphibian Xenopus luevis. Data were also collected on the ability of the oocytes to recover from the drug's inhibitory effect and on the toxicity of each drug. the data revealed that up to a 14‐fold difference exists in the inhibitory concentration 50% between substances, that recovery from the drug's inhibitory effect ranged from non‐reversible to almost complete reversibility and that toxicity, as measured by failure to exclude trypan blue, ranged from 0 to 57%. In some, but not all cases, the failure to recover from the drug's inhibitory effects could be correlated to the drug's toxic effects. Amiloride which has been shown to be a reversible inhibitor of cell proliferation in rapidly dividing mammalian cell populations has similar properties on the oocyte maturation division cycle of Xenopus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.